Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

 

Recent News and Articles on the Keywords: 0.34 + web + 129,000  Related to the article below (Last Update: 8/5/2008)

Cimarex Reports Second-Quarter 2008 Earnings of $2.68 per Share
PR Newswire (press release), NY - 56 minutes ago
... 3.20 General and administrative expense 0.30 - 0.34 Production taxes (% of oil and gas revenue) 6.5% - 7.5% Conference call and web cast Cimarex will ...XEC
The St. Joe Company Reports Second Quarter 2008 Financial Results
StreetInsider.com (subscription), MI - 5 minutes ago
JOE will also web cast the conference call live over the internet in a listen-only format. Listeners can participate by visiting the company's web site at ...JOE
College of Art Buys Area Homes
Memphis Daily News,  USA -
... $285000 for the 3448-square-foot four-plex that sits on 0.17 acres at 150 N. Tucker; and $650000 for the 6846-square-foot nine-plex that sits on 0.34 ...
Research firm: Obama outpacing McCain in Web-site traffic, online ...
Computerworld, MA - Jul 8, 2008
Barack Obama's campaign Web site outpaced visits to Sen. John McCain's official site by a 4:1 margin, according to data released Monday by market research ...
Equity One Reports Second Quarter 2008 Operating Results
WELT ONLINE, Germany - Jul 29, 2008
CONFERENCE CALL/WEB CAST INFORMATION We will host a conference call on Wednesday, July 30, 2008, at 9:00 am EST to review the 2008 second quarter earnings ...
Cogdell Spencer Inc. Reports Second Quarter 2008 Financial Results Earthtimes (press release)
all 180 news articles »  EQY - CSA - COL:EQIT
Plum Creek Timber Company, Inc. Reports Results for Second Quarter ...
MarketWatch - Jul 28, 2008
A live webcast of the conference call may be accessed through Plum Creek's Web site at www.plumcreek.com by clicking on the "Investors" link. ...
PSi Technologies Reports Second Quarter 2008 Results NewsBlaze
TTM Technologies, Inc. Reports Second Quarter 2008 Results Trading Markets (press release)
all 570 news articles »  TTMI - PSIT - PCL

WELT ONLINE
Susquehanna Bancshares, Inc. Announces Second Quarter Results
WELT ONLINE, Germany - Jul 23, 2008
Investors will have the opportunity to listen to the conference call through a live broadcast on Susquehanna?s Web site. The event may be accessed by ...
Sandy Spring Bancorp Reports Second Quarter Results MSN Money
First Security Group Announces Earnings MarketWatch
First Defiance Announces 2008 Second Quarter Earnings PR Newswire (press release)
Trading Markets (press release) - istockAnalyst.com
all 1,034 news articles »  FPFC - WB - NARA
NuStar GP Holdings, LLC Reports Better-Than-Expected Second ...
FOXBusiness - Jul 25, 2008
A live broadcast of the conference call will also be available on the company's Web site at www.nustargp.com. NuStar GP Holdings, LLC is a publicly traded ...NSH - NS
IAC Reports Q2 Results
MSN Money - Jul 30, 2008
Revenue benefited further from an increase in revenue per query and queries from Fun Web Products. Revenue per query at Ask.com grew, even excluding the ...
Kaboose Reports Record Second Quarter 2008 Results with Revenue ...
Canada NewsWire (press release), Canada - Jul 31, 2008
The webcast will be archived on the same web page for 30 days following the live call. The second quarter financial statements and related management's ...TSE:KAB - BOM:532354 - GIS
Source: Google News

Analysis of Stalk Rot Resistance and Genetic Diversity among Drought Tolerant Sorghum Genotypes …
TT Tesso, LE Claflin, MR Tuinstra - Crop Science, 2005 - Crop Sci Soc America
... single-row plots (6.5 x 0.76 m) at a population of 129000 plants ha ... This was shown
by significant correlation (r = 0.34) between clusters and geographic origins ...

[PDF] Appendix D
A Toxics - proteus.pca.state.mn.us
... These summaries can be found at the following web site: http://www.epa.gov/ttn/uatw/
hapindex.html. Page 6. ... Chloroform 0.34 83 17 94 Chromium 0.07 83 12 5 0 ...

[PDF] USER'S GUIDE FOR EVALUATING SUBSURFACE VAPOR INTRUSION INTO BUILDINGS -
USEP AGENCY - Office of Emergency and Remedial Response, Washington, DC, 2004 - earth1.epa.gov
... for the draft vapor intrusion guidance were calculated using a cancer slope factor
identified in that document, which is available on the NCEA web site. ...

[PDF] Background Document -
B Team - itrcweb.org
Page 1. Vapor Intrusion Issues at Brownfield Sites Prepared by The Interstate
Technology & Regulatory Council Brownfields Team December 2003 Background Document ...

[PDF] UV to radio centimetric spectral energy distributions of optically-selected late-type galaxies in … -
A Boselli, G Gavazzi, G Sanvito - Arxiv preprint astro-ph/0301134, 2003 - arxiv.org
... analyzed in the present paper are contained in a database that has been made available
to the international community via the Word Wide Web site GOLDMine (http ...
-

ETLA
F ECONOMY - etla.fi
... 358-9-609 900 Telefax 358-9-601 753 World Wide Web: http://www.etia.fi ... 1.00 1.00
1.00 1.00 1.00 State Owned Enterprises 0.78 0.76 0.65 0.55 0.37 0.34 Non-State ...

Process of making polypropylene fibers
JH Harrington, RE Kozulla, JFL Newport, EJ Engle, … - US Patent 5,985,193, 1999 - freepatentsonline.com
... 5079080, January, 1992, Schwarz, Process for forming a superabsorbent composite
web from fiberforming thermoplastic polymer and supersorbing polymer and products ...

Polypropylene fibers and items made therefrom -
JH Harrington, RE Kozulla, JFL Newport, EJ Engle, … - US Patent 6,458,726, 2002 - freepatentsonline.com
... Nonwoven fabrics are typically made by making a web, and then thermally bonding
the fibers together. ... The bonded web is then wound into a roll. ...

[PDF] Liquid Waste Certification Plan for Pacific Northwest National Laboratory, Rev. 2, July 2000 -
MY Ballinger, MJ McCarthy, KD Shields - 2000 - osti.gov
... Pacific Northwest has developed a Standards-Based Management System (SBMS), a
Web-based system that communicates Laboratory-wide standards, policies, procedures ...

[PDF] Liquid Waste Certification Plan for Pacific Northwest National Laboratory
MJ McCarthy, MY Ballinger - pnl.gov
... Pacific Northwest has developed a Standards-Based Management System (SBMS), a
Web-based system that communicates Laboratory-wide standards, policies, procedures ...

Source: Google Scholar

Sequential And Combination Chemotherapy Equally Effective In Treating Advanced Colorectal Cancer
Many patients with incurable advanced colorectal cancer could be offered a more gentle treatment strategy starting with a single chemotherapy drug, as an alternative to current standard initial combination chemotherapy, without compromising their survival. These are the conclusions of authors of two separate Articles published in this week's edition of The Lancet.

They believe their results challenge conventional clinical practice in this area; however, an accompanying Comment says that evidence supports the continuing use of initial combination chemotherapy.
Colorectal cancer causes over half a million deaths every year worldwide. This death toll could fall with advances in prevention, screening and treatment - but there are many patients in which controlling the cancer sufficiently to delay death and reduce symptoms is the only realistic therapeutic goal.

In the first Article, Professor Matt Seymour, University of Leeds and the Gastrointestinal Research Unit, Cookridge Hospital, Leeds, UK and colleagues at the UK National Cancer Research Institute discuss the results of the Medical Research Council FOCUS Trial. This trial is the largest randomised clinical trial ever conducted in the treatment of advanced colorectal cancer, and involved 2135 patients divided into three groups. The first group received single-drug treatment with fluorouracil for as long as it controlled their disease, followed by single-drug treatment irinotecan. The second group received fluorouracil followed by combination treatment (fluorouracil plus irinotecan or oxaliplatin), while the third group received combination chemotherapy from the outset.

The researchers found that patients in the first group had the shortest survival, but the second and third groups had similar overall survival. Toxic effects were lowest during the single-treatment fluorouracil, and quality of life scores were similar throughout all the treatment regimens.

The authors conclude: "This large randomised trial has produced a surprising result which challenges accepted standard treatment approaches in advanced colorectal cancer therapy." For the larger number of patients with more extensive metastases who will not be cured, they add: "FOCUS offers an important choice, informed by the knowledge that a decision to opt for staged treatment approach, starting with less toxic therapy and keeping active agents in reserve, entails minimal, if any, compromise in survival."
In the second Article, Professor Cornelis Punt, Department of Medical Oncology, Radboud University Nijmegen Medical Centre, The Netherlands, and colleagues report the results of the CAIRO trial. In this study, 820 patients were randomly assigned to receive either sequential treatment with capecitabine, irinotecan and oxaliplatin; or combination treatment of capecitabine plus irinotecan followed by capecitabine plus oxaliplatin. They found that median overall survival rates were similar in the two groups. Previous studies have shown at least similar efficacy and a favourable toxicity profile for capecitabine when compared with fluorouracil.

The authors conclude: "Our results show that, for patients with advanced colorectal cancer, combination treatment with all effective cytotoxic drugs was no better than their sequential use. Progression-free survival over all subsequent treatment lines was not significantly different between the study groups. Additionally, sequential treatment was associated with less toxicity during first-line treatment than was combination therapy."

"Chemotherapy remains the backbone of systemic treatment in this disease, and our results indicate that sequential treatment remains a valid treatment option for these patients."

In the accompanying Comment, Dr Hans-Joachim Schmoll, Martin-Luther University, Halle, and Dr Daniel Sergeant, Mayo Clinic, Rochester, Minnesota, USA, say: "Clinically validated prognostic and predictive factors, such as genomic tests, are needed to define in which patients more intensive therapy is worthwhile, and ideally, which specific treatment should be used.

"Until then, to maximise potential benefit for each patient, an approach based on prognosis and disease presentation with initial combination chemotherapy for most patients, reserving single-agent fluorouracil for a subgroup with less aggressive or never-resectable disease, should be the standard of care for first-line treatment of metastatic colorectal cancer.

"FOCUS and CAIRO support the use of first-line single agent fluorouracil for the latter subgroup of patients and therefore provide an ethical basis for investigating novel drugs in combination with single-agent fluoropyrimidines in future trials, to further develop the treatment armamentarium for patients with colorectal cancer."

http://www.lancet.com
 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 
 
Continue News With: News3 ; News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.